Basking Ridge, NJ, United States of America

Yuping Zhu

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 10 EPO patents. Top assignees: Merck Sharp + Dohme Corp., Other. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yuping Zhu. Retrieved from https://idiyas.com/inventor/yuping-zhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 7)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 10 (Patent Applications = 14)

Average Co-Inventor Count = 9.1

ph-index = 3

Forward Citations = 31(Granted Patents)

Location History:

Edison, NJ (US) (2014 - 2020)
Basking Ridge, NJ (US) (2015 - 2023)

Company Filing History:

12 out of 2,405

Merck Sharp + Dohme Corp.

patents

1 out of 834,513

Other

patents

Years Active: 2014-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12427187 - Glucose-responsive insulin conjugates (2025-09-30),

2. 11820805 - Conjugate based systems for controlled insulin delivery (2023-11-21),

3. 11566057 - Long-acting co-agonists of the glucagon and GLP-1 receptors (2023-01-31),

4. 11041009 - Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes (2021-06-22),

5. 10800827 - Insulin receptor partial agonists (2020-10-13),

6. 10689430 - Insulin receptor partial agonists (2020-06-23),

7. 10183981 - Insulin receptor partial agonists (2019-01-22),

8. 10017556 - Insulin receptor partial agonists (2018-07-10),

9. 9056859 - Inhibitors of the renal outer medullary potassium channel (2015-06-16),

10. 9018224 - Substituted cyclopropyl compounds useful as GPR119 agonists (2015-04-28),

11. 9018211 - Inhibitors of the renal outer medullary potassium channel (2015-04-28),

12. 8957062 - Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment (2015-02-17),

13. 8673920 - Inhibitors of the renal outer medullary potassium channel (2014-03-18),

Title: Innovator Spotlight: Yuping Zhu, Pioneering Insulin Delivery Systems

Introduction: Meet Yuping Zhu, a visionary inventor hailing from Basking Ridge, NJ (US) with an impressive portfolio of 12 patents. His groundbreaking work in the field of controlled insulin delivery has revolutionized the healthcare industry.

Latest Patents: One of Zhu's latest patents focuses on "Conjugate-based systems for controlled insulin delivery." These innovative conjugates consist of an insulin molecule linked to multiple ligands, each containing a saccharide. The framework allows for precise control over insulin release, leading to improved pharmacokinetic and pharmacodynamic properties. Additionally, Zhu has patented "Long-acting co-agonists of the glucagon and GLP-1 receptors," demonstrating his versatility and ingenuity in the field.

Career Highlights: Zhu's remarkable career includes stints at renowned companies such as Merck and Sharp & Dohme Corporation. His expertise and dedication have been instrumental in developing cutting-edge medical technologies that have made a significant impact on patient care.

Collaborations: Throughout his career, Yuping Zhu has collaborated with esteemed professionals in the industry. Notable coworkers include Songnian Lin and Lin Yan, who have worked closely with Zhu to bring his innovative ideas to fruition.

Conclusion: In conclusion, Yuping Zhu stands as a trailblazing inventor whose contributions to controlled insulin delivery systems and co-agonists of the glucagon and GLP-1 receptors have reshaped the landscape of healthcare. His relentless pursuit of innovation and collaboration with industry experts have cemented his legacy as a visionary in the field.

Profile summary based on public USPTO records.